Australian (ASX) Stock Market Forum

ATH - Alterity Therapeutics

Joined
9 November 2005
Posts
101
Reactions
0
Yeah I know its just another biotechnology company but it would seem to me this one has some potential with its research into Alzheimers disease. Any major breakthrough here could lead to massive potentil for profits.

Anybody got any positive information on this one?


Pat
 
Well reading the news continually coming out this company may have legs. They have released some very positive news stories out there. Their clincal trials have been successfull as well.
 
There has been a nice annoucement today showing success in their trials. I am expecting this stock to move during the day
 
These have been rising nicelsy over the last week up 11c and its reported today they are releasing their findings on the 30th. Seriosuly worth a look I reckon.
 
Quite a nice little update from Prana. Hopefully this good news will lead somewhere like a higher shareprice.
 
The concept sounds great, but the SP has been asleep throughout the whole rally. In fact, i think its gone down, despite the odd semi encouraging announcement. I think the market is expecting more guidance on Phase IIb trials. Either way, i think I'll be waiting a long time for serious sp increases, even assuming all goes well.
 
Do we have any PBT holders around here? I've been reading into it and following reports like the Southern Cross Equities and it could be promising, opinions and thoughts?
 
What goes up....

PBT has just announced a capital raising of $6.2m with the private sale to sophisticated investors of 27 m shares at .225 c. This capitalizes exceptionally well on yesterdays announcement of just how effective their Alzheimer treatment is going to be.

Trouble is that the shares had jumped to 37c on opening today and when the placement news came through the shares have dropped like a stone to 25c. Interesting...:rolleyes:

I think there may be some very crisp fingers around this evening..
 
What goes up....

PBT has just announced a capital raising of $6.2m with the private sale to sophisticated investors of 27 m shares at .225 c. This capitalizes exceptionally well on yesterdays announcement of just how effective their Alzheimer treatment is going to be.

Trouble is that the shares had jumped to 37c on opening today and when the placement news came through the shares have dropped like a stone to 25c. Interesting...:rolleyes:

I think there may be some very crisp fingers around this evening..

I checked the price later in the day was :confused: and then saw about the capital raising :eek:

whats your thoughts on the future?
 
What goes up....

PBT has just announced a capital raising of $6.2m with the private sale to sophisticated investors of 27 m shares at .225 c. This capitalizes exceptionally well on yesterdays announcement of just how effective their Alzheimer treatment is going to be.

Trouble is that the shares had jumped to 37c on opening today and when the placement news came through the shares have dropped like a stone to 25c. Interesting...:rolleyes:

I think there may be some very crisp fingers around this evening..

I'm very happy I got out when I did. I got in yesterday in the late afternoon at 22.5c and read the whole article regarding the Alzheimers treatment vaccinations etc. etc. Then, I was in university classes this morning with my laptop computer and saw the "indicative price" (on Commsec) for it at 29c in pre-open trading, and then it went to 29.5c, then 30c, then 30.5c.........and I was like "WOW, I can't believe this". I felt it was going to go up this morning, BUT not by the amount it did, especially after the gap up from yesterday. It sky-rocketed up to 37c at open (going up to 37.5c at its peak). I got out at 35.5c (hence making a nice 58% gain, my highest since I joined the stock market 2 months ago) when I saw the number of sellers starting to increase a lot (I don't know if this is referred to as 'filling the gap', someone can verify this terminology for me). Then, on my occasional checks I had a look at the price and it was plateauing around the 33-34c mark. Then in the later afternoon, had a look and again........WOW! I couldn't believe when I saw it just went right back down to around 24c.

This stock reminds me very much of my experience with AIV last month. It was just hovering around at 7.7c, then on some announcement, in the space of 3 minutes or so, shot up to 11.5c, then plateaued around 9.5c before going back down to 7.7c and below that by the end of that day. It's now around 6c or so I believe
 
hopefully my luck will turn around :banghead:
congrats thou!

where can I find the indicative price on pre open in commsec?

do you have realtime charts in commsec as well?
 
This is always going to be an interesting share.

A successful treatment for Alzheimers is almost the Holy Grail. In terms of potential profit as well as actually being a worthwhile product it is right up there.

Prana has been on this path for many years now. In fact I can remember a friend of mine trying to encourage interest from me at least 7-8 years ago. It does look as if it is getting closer to reality and if that is the case then this share will certainly go through the roof.

On balance I think it is worth a small speculative punt with a chance of being a big success. ( Mind you I have run out of the readies for any more speculative punts!!) The fact that they now have another $6.2 m in kitty to keep the research going is good news. As usual DYOR and in particular be aware of how long it has taken for this company to get this far..:2twocents
 
Yes I got burnt on this one, but am going to hang on for the duration I think. Finding a cure for Alzheimers has got to be up there with a cure for cancer or aids. There is a massive market. It seems they have come quite a long way now after many years of research and have some very impressive clinical results.

There was talk of them getting a large grant from the previous Victorian govt, but now there has been a change of govt perhaps it may not happen. You would think that it would be worthwhile investment for a govt of any political persuasion though, and I would not be surprised if we got news on this front to help buoy the price for the new placement holders.

I wonder how many years it would take them to get the drug through all the approval channels if they continue to prove their technology?
 
I thought it might be a good time to bring the thread back to life!!

It closed @ 43c today after an intra-day high of 45.5c on just over a million turnover. It hasn't been this since October 2008, so they must be something right for the price to have doubled in just 3 to 4 months.

Anyone here who knows what is making the stock suddenly so popular?
 
Up again today.

PBTs.gif
 
Prana’s PBT2 Reverses Memory Loss in Normal Ageing

• PBT2 Increases numbers of Neurons in the brain
• PBT2 increases numbers of Synapses in the brain
• PBT2 increases NMDA and AMPA levels
• PBT2 increases Protein Phosphatase 2a (PP2a)

“It is very exciting to discover that PBT2 not only helps clear amyloid from the brain, but is promoting the birth of new nerve cells in a part of the brain that is particularly affected by Alzheimer’s disease, the hippocampus. This now adds to the predicted beneficial properties of PBT2 for the treatment and prevention of Alzheimer’s disease,” commented Dr Rudy Tanzi, Professor of Neurology at Harvard Medical School, Vice Chair of Neurology at Massachusetts General Hospital, and Prana’s Chief Scientific Advisor.

http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=397272

Today's announcement was warmly received by the market - up 40% (closed @ 54.5c) on larger than normal volume.
 
piggybank

I bought a fairly large number of shares 3 months ago.
We don't get the phase 2 results till March, but this company has a good track record and I am reasonably confident that the results will be good. Phase 3 may yet be another story however I do think this company is in the box seat as it now appears big pharma expended money on the wrong theory.

The reason for the big rise is that if it could help in other memory problems despite Alzheimers then this could be even more the drug of the decade.

As for any biotech, you shouldn't put more than 5% of your capital in it.
 
Top